Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Octreotide alone or with prednisone in advanced, recurrent thymoma
NCT00003283Phase 2Completed
- Sponsor
- Eastern Cooperative Oncology Group
- Start
- Oct 1998
- Primary completion
- Sep 2003
- Modality
- Peptides
- Countries
- 2
01
Overview
A Phase 2 trial of octreotide in thymoma, thymic carcinoma (TC), sponsored by Eastern Cooperative Oncology Group. Started Oct 1998; status: completed.
02
Drugs
octreotide
03
Conditions
thymomathymic carcinoma (TC)
Beyond the preview
Go deeper on NCT00003283.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003283.